Komori
Other Disclosures4461DKS Co.Ltd.Materials and Chemicals

A New Strategy for Dementia Prevention: Co-Hosting an Academic Seminar on Biomarker Research and the Potential of the Product “ナトリード”

第一工業製薬 will co-host an academic society luncheon seminar on dementia prevention with researchers from the University of Occupational and Environmental Health, Japan. It will present its research-stage cyclic peptide derived from silkworm Cordyceps, NATLEAD, as an example of a potential application in dementia prevention.

Worth reading
47Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Announced details

NATLEAD, a cyclic peptide derived from silkworm Cordyceps
Applicable field (uses covered by this announcement)

Dementia prevention, risk stratification using biomarkers, and intervention using naturally derived ingredients

Launch date12 September 2026 (Saturday), 12:20–13:10 (scheduled seminar time)
Relationship between the counterparty and the company
DKS Co.Ltd.4461
Relationship with the Company

Co-host of a luncheon seminar on dementia prevention. Capital, personnel and ordinary business relationships: not disclosed.

CounterpartyDepartment of Neurology, School of Medicine, University of Occupational and Environmental Health, Japan

The department conducts research and provides medical care relating to neurological diseases and dementia. Its professor is Adachi Hiroaki (足立弘明). Location, capital and year established: not disclosed.

Location (as indicated in this announcement)

G Messe Gunma (12-24 Iwaoshimachi, Takasaki, Gunma Prefecture)

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

Official website of the 15th Annual Meeting of the Japanese Society for Dementia Prevention

Announced details
ItemDetails
Names of Products / Services CoveredNATLEAD, a cyclic peptide derived from silkworm Cordyceps
CounterpartyDepartment of Neurology, School of Medicine, University of Occupational and Environmental Health, Japan
Counterparty overviewThe department conducts research and provides medical care relating to neurological diseases and dementia. Its professor is Adachi Hiroaki (足立弘明). Location, capital and year established: not disclosed.
Relationship with the CompanyCo-host of a luncheon seminar on dementia prevention. Capital, personnel and ordinary business relationships: not disclosed.
Launch date12 September 2026 (Saturday), 12:20–13:10 (scheduled seminar time)
Applicable areaDementia prevention, risk stratification using biomarkers, and intervention using naturally derived ingredients
LocationG Messe Gunma (12-24 Iwaoshimachi, Takasaki, Gunma Prefecture)
SourceOfficial website of the 15th Annual Meeting of the Japanese Society for Dementia Prevention
Items this document does not state (10)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Interest is growing in maintaining cognitive function and extending healthy life expectancy as the population ages. In addition, there are expectations that identifying risks before the onset of dementia will lead to preventive measures and health management tailored to each individual's condition.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
A New Strategy for Dementia Prevention: Co-Hosting an Academic Seminar on Biomarker Research and the Potential of the Product “ナトリード” | DKS Co.Ltd. (4461) timely disclosure | Komori